LSE - Delayed Quote EUR

Glanbia plc (GLB.L)

17.50 0.00 (0.00%)
At close: 5:24 PM GMT+1
Loading Chart for GLB.L
DELL
  • Previous Close 17.50
  • Open 17.70
  • Bid 16.90 x --
  • Ask 18.10 x --
  • Day's Range 17.38 - 17.73
  • 52 Week Range 13.08 - 18.52
  • Volume 189,822
  • Avg. Volume 83,000
  • Market Cap (intraday) 46.452M
  • Beta (5Y Monthly) 0.55
  • PE Ratio (TTM) 0.14
  • EPS (TTM) 1.21
  • Earnings Date --
  • Forward Dividend & Yield 0.35 (2.02%)
  • Ex-Dividend Date Mar 21, 2024
  • 1y Target Est 19.00

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; property leasing; business services; management solutions; weight management; flavor solutions; and bioactive solutions businesses. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, SlimFast, think!, Amazing Grass, Body & Fit, and LevlUp brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

www.glanbia.com

5,534

Full Time Employees

December 30

Fiscal Year Ends

Recent News: GLB.L

Performance Overview: GLB.L

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

GLB.L
23.83%
ISEQ All Share
13.36%

1-Year Return

GLB.L
31.06%
ISEQ All Share
17.10%

3-Year Return

GLB.L
47.21%
ISEQ All Share
21.80%

5-Year Return

GLB.L
15.58%
ISEQ All Share
51.85%

Compare To: GLB.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GLB.L

Valuation Measures

As of 4/19/2024
  • Market Cap

    4.65B

  • Enterprise Value

    4.98B

  • Trailing P/E

    14.51

  • Forward P/E

    13.05

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.93

  • Price/Book (mrq)

    2.29

  • Enterprise Value/Revenue

    0.92

  • Enterprise Value/EBITDA

    8.88

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.35%

  • Return on Assets (ttm)

    5.45%

  • Return on Equity (ttm)

    16.86%

  • Revenue (ttm)

    5.43B

  • Net Income Avi to Common (ttm)

    347.6M

  • Diluted EPS (ttm)

    1.21

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    413.7M

  • Total Debt/Equity (mrq)

    36.19%

  • Levered Free Cash Flow (ttm)

    272.28M

Research Analysis: GLB.L

Analyst Price Targets

19.00
19.00 Average
17.50 Current
19.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

People Also Watch